Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 137.00
-3.50 (-2.49%)
May 8, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 9.15 billion as of May 8, 2026. Its market cap has increased by 14.64% in one year.
Market Cap
9.15B
Enterprise Value
6.85B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
137.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 9.15B, an increase of 256.79%. That is a compound annual growth rate of 25.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 9.15B | -54.93% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 16.74B |
| ScinoPharm Taiwan | 15.66B |
| Synmosa Biopharma | 15.56B |
| YungShin Global Holding | 14.73B |
| Foresee Pharmaceuticals | 12.45B |
| Handa Pharmaceuticals | 11.70B |
| Standard Chemical & Pharmaceutical | 10.92B |
| Formosa Laboratories | 6.53B |